| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/15/2007 | CN101018567A Induction of apoptosis in Toll-like receptor expressing tumor cells |
| 08/15/2007 | CN101018551A Porphyrin derivatives and their use in photon activation therapy |
| 08/15/2007 | CN101016340A Fusion polypeptide and use thereof in treatment of tumor and cell growth abnormity correlated disease |
| 08/15/2007 | CN101016329A Method of preparing cyclopamine from jervine |
| 08/15/2007 | CN101016327A Toad sterene compounds, preparing method and application thereof |
| 08/15/2007 | CN101016326A Toad sterene compounds and application thereof in pharmaceutical preparation |
| 08/15/2007 | CN101016324A Nucleic acid molecule RTN4BSR62 and application in preparation of anti-cancer drugs |
| 08/15/2007 | CN101016319A Benzoisoselenothiazolidone aminosugar derivative, preparing method and application therheof |
| 08/15/2007 | CN101016301A Triazole miazines derivative |
| 08/15/2007 | CN101016294A Substituted indole-3-oxalamide derivative with multiple bioactivity |
| 08/15/2007 | CN101016286A Extraction method for extraction and pharmaceutical containing the same |
| 08/15/2007 | CN101016262A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative |
| 08/15/2007 | CN101016236A Diterpenes compound A in sarcodon scabrosus karst and tumour cell proliferation resistant active |
| 08/15/2007 | CN101015699A Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy |
| 08/15/2007 | CN101015698A Medicament using rare earth transferring complex compound as vector |
| 08/15/2007 | CN101015696A Antisense oligonucleotide-carbon nanotube medicament vector |
| 08/15/2007 | CN101015689A Tumour polypeptide vaccine based on angiotensin II |
| 08/15/2007 | CN101015688A Molecular antigen array |
| 08/15/2007 | CN101015687A Preparing technique for rapid extraction of antigastrin release tumor vaccine |
| 08/15/2007 | CN101015680A Medicine for improving immunity and treating malignant tumour and preparation process thereof |
| 08/15/2007 | CN101015679A Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 08/15/2007 | CN101015645A Medicine for treating cancer and preparing method therefor |
| 08/15/2007 | CN101015573A Patrinai villosa dropping pill and its preparing process |
| 08/15/2007 | CN101015572A Extraction method of korean pine cone extractive |
| 08/15/2007 | CN101015571A Chinese caterpillar fungus polysaccharide buccal tablets and its preparing process |
| 08/15/2007 | CN101015563A Intravenous injection microemulsion preparation of teniposide |
| 08/15/2007 | CN101015551A Preparing method of triptolide stereoscopic stable liposome nano granule |
| 08/15/2007 | CN101015550A Preparing method of triptolide molecule microcapsule |
| 08/15/2007 | CN101015549A Preparing and detecting method of triptolide liposome nano granule |
| 08/15/2007 | CN101015548A Compound paclitaxel preparation containing phospholipid dispersant and its preparation method |
| 08/15/2007 | CN101015547A Docetaxel liposome formulation and preparation method thereof |
| 08/15/2007 | CN101015539A Preparation of nedaplatin freeze-dried powder injection |
| 08/15/2007 | CN101015526A Topotecan liposome and preparation method therefor |
| 08/15/2007 | CN101015525A Paclitaxel liposome and preparation method therefor |
| 08/15/2007 | CN101015521A Anticancer composition loading both antimetabolite medicament and synergistic agent |
| 08/14/2007 | US7256277 Nucleotide and protein sequence of mammastatin and methods of use |
| 08/14/2007 | US7256274 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 08/14/2007 | US7256271 Cancerous disease modifying antibodies |
| 08/14/2007 | US7256267 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 08/14/2007 | US7256214 5,7,3',4'-Tetrahydroxy-5'-C-geranylflavanone (isonymphaeol-B), isolated from an Okinawa propolis; microbiocide, antitumor agent, food, beverage and cosmetic preservative; antioxidant food supplement |
| 08/14/2007 | US7256213 Taxanes having a C10 carbonate substituent |
| 08/14/2007 | US7256210 7-amido-isoindolyl compounds and methods of their use |
| 08/14/2007 | US7256201 Selective estrogen receptor-β ligands |
| 08/14/2007 | US7256194 Compounds that inhibit factor Xa activity |
| 08/14/2007 | US7256189 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors |
| 08/14/2007 | US7256188 3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH antagonists |
| 08/14/2007 | US7256183 Administering a nucleotide receptor agonist (such as adenosine triphophate or uridine triphosphate); sinusitis, rhinitis, conjunctivitis, asthma, dermatitis, inflammatory collagen vascular diseases, glomerulonephritis; antiallergens |
| 08/14/2007 | US7256178 Physiologically active substances |
| 08/14/2007 | US7256043 Transfection complexes |
| 08/14/2007 | US7256028 Methods for screening compounds that modulate lipid metabolism |
| 08/14/2007 | CA2206758C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/09/2007 | WO2007090095A2 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics |
| 08/09/2007 | WO2007089544A2 Biodegradable non-ophthalmic implants and related methods |
| 08/09/2007 | WO2007089507A1 A3 adenosine receptor allosteric modulators |
| 08/09/2007 | WO2007089149A2 Water-soluble cc-1065 analogs and their conjugates |
| 08/09/2007 | WO2007089051A1 Composition for treating cancer comprising oligonucleotide and non-toxic lps |
| 08/09/2007 | WO2007089043A1 Liposome preparation |
| 08/09/2007 | WO2007089018A1 Triazole derivative |
| 08/09/2007 | WO2007088952A1 Liposome preparation comprising substance having anti-tumor activity |
| 08/09/2007 | WO2007088900A1 Double-stranded rna inducing cell death |
| 08/09/2007 | WO2007088869A1 Method for producing denatured substance of lactalbumin |
| 08/09/2007 | WO2007088651A1 JOINT USE OF TGF-β SIGNAL INHIBITOR AND ANTITUMOR AGENT |
| 08/09/2007 | WO2007088460A2 Tgf-beta modulators and use thereof |
| 08/09/2007 | WO2007088041A1 Compounds for the inhibition of integrins and use thereof |
| 08/09/2007 | WO2007088034A2 Tuberous sclerosis treatment |
| 08/09/2007 | WO2007088014A1 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors |
| 08/09/2007 | WO2007087684A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 08/09/2007 | WO2007071970A3 Combination of azd2171 and pemetrexed |
| 08/09/2007 | WO2007071963A3 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 08/09/2007 | WO2007071205A3 A taxane derivative containing pharmaceutical composition with improved therapeutic efficacy |
| 08/09/2007 | WO2007068354A8 Means and methods for the treatment of tumorous diseases |
| 08/09/2007 | WO2007064872A3 Urea compounds useful in the treatment of cancer |
| 08/09/2007 | WO2007062875B1 Heteroaromatic sulfonamide prodrugs |
| 08/09/2007 | WO2007060012A3 Use of l-phenylalanine conjugated to an emitting isotope for therapy of hormone dependent carcinoma |
| 08/09/2007 | WO2007059404A3 Duocarmycin derivatives as novel cytotoxic compounds and conjugates |
| 08/09/2007 | WO2007059202A3 Pyrazolyl urea derivatives useful in the treatment of cancer |
| 08/09/2007 | WO2007055941A3 Histone deacetylase inhibitors with aryl-pyrazolyl motifs |
| 08/09/2007 | WO2007054725A3 Combination of a cdk-inhibitor and a hdac-inhibitor |
| 08/09/2007 | WO2007054283A3 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 08/09/2007 | WO2007053343A3 Compounds and compositions as protein kinase inhibitors |
| 08/09/2007 | WO2007053194A3 Modulation of cell barrier dysfunction |
| 08/09/2007 | WO2007044729A3 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 08/09/2007 | WO2007041637A3 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 08/09/2007 | WO2007027751A3 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 08/09/2007 | WO2007024843A3 Pyrimidinyl-pyrazole inhibitors of aurora kinases |
| 08/09/2007 | WO2006130688A3 Compounds for inhibiting cathepsin activity |
| 08/09/2007 | WO2006117217A3 Novel use of spiegelmers |
| 08/09/2007 | US20070185174 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 08/09/2007 | US20070185170 1,1'-(benzene-1,3-diylmethylene)bis[4-(4-chloro-N-methylanilino)pyridinium]dibromide, that inhibit phosphorylcholine biosynthesis by selective blocking of the choline kinase enzyme in tumor cells or in cells affected by parasitic infections; anticarcinogenic or antitumor agents; fungicides; viricides |
| 08/09/2007 | US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors |
| 08/09/2007 | US20070185143 Anticarcinogenic agents, antimetastasis agents; angiogenesis inhibitors; transplant rejection |
| 08/09/2007 | US20070185134 Inhibitors of cyclin dependent kinases as anti-cancer agent |
| 08/09/2007 | US20070185091 Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing Them |
| 08/09/2007 | US20070185071 a compound containing cyclic tetrapeptide coupled to amide, ester, ketone groups; apoptosis and cell differentiation inducer; cancer metastasis and angiogenesis inhibitor; catalytic hydrogenation, acid treatment, fluoride anion treatment, or hydrolysis for deblocking; coupling cyclic tertrapeptide |
| 08/09/2007 | US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 08/09/2007 | US20070185041 bis-(3-deoxy-3-(4-(methylaminocarbonyl)-1H-[1,2,3]-triazol-1-yl)-beta-D-galactopyranosyl)sulfane; pharmacokinetics |
| 08/09/2007 | US20070185039 bis-(3-deoxy-3-benzamido- beta -D-galactopyranosyl)sulfane for example; inhibitors of galectin-3; anticancer, septic shock |
| 08/09/2007 | US20070185037 Sulfated oligosaccharide derivatives |
| 08/09/2007 | US20070185013 Use of chk1 inhibitors to control cell proliferation |
| 08/09/2007 | US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |